- BMEA -0.11%
Biomea Fusion, Inc. (BMEA): Why Did Analysts Give This Biotech Penny Stock a Moderate Buy Rating?
Yahoo Finance · 6 days ago
Open | 4.3900 |
High | 4.4400 |
Low | 4.1500 |
Mkt Cap | 156.18M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 4.3500 |
52 Wk. Low | 3.6100 |
52 Wk. High | 23.9200 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | - | - |
Net Income | -39.06M | - |
Diluted EPS | -1.09 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$1.07 | - |
Q1 2024 | -$0.99 | -$1.09 |
Q4 2023 | -$0.85 | -$0.98 |
S&P 500^GSPC | 5,548.07+11.05 (+0.20%) |
Dow 30^DJI | 39,304.90-3.10 (-0.01%) |
Nasdaq^IXIC | 18,285.57+97.27 (+0.53%) |
Tesla, Inc.TSLA | 249.70+1.34% |
Apple Inc.AAPL | 224.46+1.31% |
126.80-1.15% |